# Zynteglo

NDC: 73554-3111
Generic name: betibeglogene autotemcel
Labeler / Manufacturer: Genetix Biotherapeutics Inc.
Product type: CELLULAR THERAPY
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20220817

FDA application: BLA125717

## Active ingredients

- BETIBEGLOGENE AUTOTEMCEL: 20000000 1/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73554-3111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73554-3111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86931613-c262-47f5-8202-bc31fa69ad3d